Frontier Biotechnologies Gains NMPA Approval for Albuvirtide Phase II Study
Nanjing-based Frontier Biotechnologies Inc. has announced receiving approval from the National Medical Products Administration (NMPA)...
Wanbangde’s Huperzine A Receives FDA Clearance for HIE Study
China’s Wanbangde New Building Materials Co., Ltd (SHE: 002082) has announced receiving clearance from the...
FDA Approves Datroway for HR+/HER2- Breast Cancer Treatment
Datroway (datopotamab deruxtecan-dlnk, Dato-Dxd), a Trop-2-directed antibody and topoisomerase inhibitor conjugate co-developed by Japan-based Daiichi...
Allist Pharmaceuticals Gains NMPA Approval for Furmonertinib Clinical Study
Shanghai-based biotech Allist Pharmaceuticals Co., Ltd has announced receiving approval from the National Medical Products...
NHSA Seeks Expert Opinions on VBP Drug Quality and Efficacy
The National Healthcare Security Administration (NHSA) has released a letter titled “Letter on Requesting Assistance...
Junshi Biosciences’ Toripalimab Gains TGA Approval for Nasopharyngeal Carcinoma
China-based Shanghai Junshi Biosciences Co., Ltd (HKG: 1877, SHA: 688180) has announced receiving marketing approval...
Inscinstech Secures C-Series Financing for Biopharma Expansion
Inscinstech Co., Ltd., a leading intelligent technology company based in Suzhou, has successfully completed a...
Raytone Bio Completes Angel Round to Advance iSus® Platform
Raytone Bio, a Shenzhen-based biopharmaceutical company, has announced the completion of a multi-million RMB Angel...
Aosaikang’s Limertinib Approved for EGFR T790M-Mutated NSCLC
Jiangsu Aosaikang Pharmaceutical Co., Ltd (ASK Pharm, SHE: 002755) has recently received approval from the...
Johnson & Johnson Submits NDA for TAR-200 in High-Risk Bladder Cancer
US-based Johnson & Johnson (J&J, NYSE: JNJ) has announced the initiation of the submission of...
Eli Lilly’s Omvoh Approved by FDA for Crohn’s Disease Treatment
US major Eli Lilly and Company (NYSE: LLY) has announced receiving marketing approval from the...
IVIEW Therapeutics Secures Series A++ Funding for Ophthalmology Pipeline
IVIEW Therapeutics Inc., an ophthalmology biotech operating out of the US and China, has reportedly...
Boehringer Ingelheim’s Iclepertin Fails to Meet Phase III Study Endpoints
German giant Boehringer Ingelheim has disclosed negative top-line results from the Phase III CONNEX study...
Telix Pharmaceuticals’ TLX591-CDx Approved in Europe via Decentralized Procedure
Australia-based Telix Pharmaceuticals Ltd (ASX: TLX) has announced that the marketing filing in Europe via...
NMPA Implements Regulatory Reforms for Drug and Medical Device Industries
The National Medical Products Administration (NMPA) has released a notification regarding the implementation of the...
Daiichi Sankyo Acquires Gatipotuzumab IP Rights for $132.5M
Japan-based Daiichi Sankyo Company, Ltd (TYO: 4568) has announced an investment of USD 132.5 million...
NHSA Pushes for Real-Time Settlement Reform in Basic Medical Insurance
The National Healthcare Security Administration (NHSA) has released a notification to promote the real-time settlement...
a16z Bio + Health Launches Biotech Ecosystem Venture Fund
Andreessen Horowitz (a16z) Bio + Health has announced the establishment of the Biotech Ecosystem Venture...
Impact Therapeutics’ Senaparib Cleared by NMPA for Ovarian Cancer Therapy
China-based Impact Therapeutics has announced receiving marketing clearance from the National Medical Products Administration (NMPA)...
Siemens Lays Foundation for New Medical Equipment Base in Shenzhen
Siemens (Shenzhen) Magnetic Resonance Co., Ltd., a wholly-owned subsidiary of Siemens Ltd., China, has officially...